
Monamra 5mg Tablet MD
Marketer
Amra Remedies
Salt Composition
Montelukast (5mg)
Overview Monamra 5mg Tablet MD
Pediatric patients can use Monamra 5mg Tablet MD to prevent asthma episodes. It also alleviates breathing problems triggered by intense physical exertion. This medication is also effective for seasonal allergies, including nasal congestion, sneezing, and itchy, watery eyes. Administer Monamra 5mg Tablet MD to your child at the prescribed dosage and frequency, consistently before or after meals. Asthma prevention may require several weeks of regular use. For asthma, give the medication in the evening or two hours prior to physical activity. For allergies, evening administration is generally optimal, timed to coincide with symptom onset. If both asthma and allergies are present, evening dosing is recommended. If your child vomits within 30 minutes of taking the medicine, repeat the dose; otherwise, omit the dose if it's near the next scheduled time. Improvement may be noted after several doses, but complete the prescribed course for optimal results. Discontinuing the medication prematurely could worsen your child's condition. Minor, transient side effects such as fever, headache, stomach pain, and diarrhea are possible; these usually resolve as your child adjusts. Persistent or bothersome side effects warrant immediate consultation with your child's physician. Inform your child's doctor of all current medications and provide a comprehensive medical history, including prior allergies, heart conditions, blood disorders, vascular problems, birth defects, airway obstructions, lung abnormalities, skin conditions, liver dysfunction, and kidney impairment. This information is essential for accurate dosage and treatment planning.
Primary Ingredients of Monamra 5mg Tablet MD
No information provided. Please provide the text you wish me to rephrase.
Uses of Monamra 5mg Tablet MD
Allergy symptom relief: Asthma prevention and treatment for allergic rhinitis.
Major Benefits of Monamra 5mg Tablet MD:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Avoid handling the tablets with damp hands. Place the tablet in your mouth; however, refrain from swallowing immediately. Monamra 5mg Tablet MD can be consumed with or without food; nevertheless, consistent timing is recommended.
Common Side effects of Monamra 5mg Tablet MD:
- Headache
- Diarrhea
- Abdominal pain
- Fever
- Upper respiratory tract infection
- Cough
- Sore throat
- Runny nose
- Sinus inflammation
- Ear inflammation
How to use Monamra 5mg Tablet MD:
Administer this medication according to your physician's prescribed dosage and schedule. Avoid handling the tablets with damp hands. Place the tablet in your mouth, but refrain from immediate swallowing. Monamra 5mg Tablet MD can be consumed with or without food; however, consistent timing is recommended.
How Monamra 5mg Tablet MD works:
Monamra 5mg tablets (MD) counteracts leukotrienes, inflammatory chemical messengers, thereby lessening airway and nasal swelling and alleviating associated symptoms.
SAFETY ADVICE
KidneySAFE IF PRESCRIBED
Monamra 5mg Tablet MD presents no safety concerns for use in patients with kidney disease and requires no dosage modification. Nevertheless, patients with severe kidney impairment should seek their pediatrician's advice.
LiverSAFE IF PRESCRIBED
Monamra 5mg Tablet MD presents no safety concerns for patients with liver impairment; dosage modification is unnecessary. Nevertheless, for children with severe hepatic dysfunction, physician consultation is advised.
What if you forget to take Monamra 5mg Tablet MD :
Remain calm. Unless otherwise directed by your pediatrician, administer the missed dose immediately upon recollection. However, omit the missed dose if the next scheduled dose is imminent. Avoid doubling the dose to compensate, and adhere to the prescribed medication schedule.
Facts to Know About Monamra 5mg Tablet MD
| Label | Value |
|---|---|
| Chemical Category | Diarylpropane Derivative |
| Developing Good Habits | No. |
| Treatment Category | Breathing |
| Action Class | Leukotriene inhibitors |
